Johnson & Johnson To Stop Opioid Sale In US Under $230 Million Settlement

Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly opioid crisis in the United States, will stop making or selling the drugs in the US under a $230 million settlement...